Important Notes
This annual report is prepared to provide a comprehensive understanding of the company's economic growth, financial status, and future development plans. Investors are encouraged to review the full annual report.
Company Overview
- Company Introduction
| Stock Name | Industry | Stock Code |
|---|---|---|
| [blank] | [blank] | 002737 |
| Registered Office | Business Type | Legal Representative |
|---|---|---|
| [blank] | [blank] | [blank] |
Main Business and Product Introduction
(1) Main Business
The company focuses on the pharmaceutical industry, emphasizing "health" and "well-being." It aims to enhance its market position and provide innovative solutions to meet consumer needs.
(2) Company Development Strategy
In the economic process, the company aims to enhance product quality and safety, ensuring sustainable growth. It will continue to innovate and adapt to market demands.
(3) Industry Overview
The company has maintained a strong market presence and will leverage its strengths to expand its product offerings and market share.
Key Financial Data and Financial Indicators
(1) Recent Key Financial Data
| Item | 2025 Year-End | 2024 Year-End | Year-on-Year Growth | 2023 Year-End |
|---|---|---|---|---|
| Total Revenue | 5,328,317,057.41 | 5,825,875,967.73 | -8.54% | 6,881,912,554.92 |
| Total Assets | 3,838,301,016.39 | 4,379,138,713.78 | -12.31% | 4,763,410,300.18 |